Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children

Huseynova Ilhama Yelmar; Hasanov Alekber Qazanfar; Mammadova Fakhriya Makhmud; Gafarov Ismayıl Adil

doi:doi:10.11648/j.ajp.20230903.21

| Peer-Reviewed

Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children

Huseynova Ilhama Yelmar, Hasanov Alekber Qazanfar, Mammadova Fakhriya Makhmud, Gafarov Ismayıl Adil

Published in American Journal of Pediatrics (Volume 9, Issue 3)

Received: 24 July 2023 Accepted: 10 August 2023 Published: 22 August 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Today, respiratory diseases are one of the most widespread pathologies of children, causing maximum morbidity. The aim of our study was to determine and analyze differences in clinical and laboratory data and outcomes among children hospitalized with respiratory diseases of COVID-19 and other etiologies. For this purpose, 164 patients under the age of 17 were involved in the study. Patients were divided into two groups: Group I included 89 (54.3%) patients diagnosed with CKD (upper respiratory tract diseases of various etiologies), Group II included 75 (45.7%) patients diagnosed with COVID-19 (PCR positive) pneumonia. During the clinical examination, intoxication, indigestion, auscultatory changes in the lungs, loss of sense of smell, muscle pains, etc., upper respiratory tract damage syndrome, catarrhal symptoms, rhinitis, hyperemia of yawning at various levels during CRX were more manifested during the clinical examination. In both comparison groups of sick children, the main leading symptoms in general were fever 122 (74.4%), cough 133 (81.1%). An increase in the concentration of pro-inflammatory cytokines (IL-1β, IL-6, Il-18) was observed in the blood of patients during both pathologies. Cytokine levels were more prominent increased during COVID-19 compared to ARDs. This indicates the severity of the inflammatory process during COVID-19. The study of the level of pro-inflammatory cytokines in the blood serum of COVID-19 patients allows to determine the progress and severity of the inflammatory process.

Published in	American Journal of Pediatrics (Volume 9, Issue 3)
DOI	10.11648/j.ajp.20230903.21
Page(s)	171-179
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Acute Respiratory Diseases, COVID-19, Children, Clinical Indicators

References

[1]	Quach A., Tosif S., Graham S. M. et al. Quality of care for children with acute respiratory infection in health facilities: a comparative analysis of assessment tools. // J. Global Health. 2022, vol. 12, p. 10003. doi: 10.7189/jogh.12.10003.
[2]	Hasanov A. Q,. Huseynova İ. E. The level of cytokines IL-21 and γ-İNF in children of early age with respiratory diseases // Azerbaijan Medical Journal. 2021, №4. p. 36-40.
[3]	Yen C. Y., Wu W. T., Chang C. Y., et al. Viral etiologies of acute respiratory tract infection among hospitalized children-a comparison between single and multiple viral infection // Microbiol. İmmunol. İnfect. 2019. v. 52 (6), p. 902-910.
[4]	Hüseynova İ. E., Hasanov A. Q,. Qafarav İ. A. Clinical characteristics of with COVID-19 pneumonia // İnternational Journal of Medical, Pharmacy and Drug Research 2023, vol. 7, No. 3, p. 1-8.
[5]	Lu X., Zhang L., Du H. et al. SARS-CoV-2 infection in children. // New England Journal of Medicine, - 2020. v. 382, - p. 1663-1665.
[6]	Dalkiran T., Kara E. M.. Ünsal V., et al. Clinical and cytokine profile of children with COVID-19: a report from Turkey // Cures, 2023, vol. 15 (4). p. 37139.
[7]	Dong Y., Mo X., Hu Y. et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China // J. Emerg Med. 2020. v. 58 (4), p. 712-713.
[8]	Kushnareva M. V., Vinogradova T. V., Parfenov V. V. et al. Specific feature of the immune ststus and interferon system of inflants // Rossiyskiy Vestnik Perinatoloji and Pediartii. 2016. № 3, с. 12-21.
[9]	Ma Y., Lu L. Clinical diagnosis and teatment characteristics of acute respiratory infection in children and new developtments in laboratory testing. // Open Journal of Pediatrics. 2021, vol. 11. p. 114-124.
[10]	Wang S. Y., Zhang T. T., Zhang X. M. et al. Epidemiological characteristics and economic burden of acute respiratory disesses in children under 5 year old in Gansu area. // China maternal and Child Health Gare. 2020, vol. 35, p. 2548-2552.
[11]	Siddiqui M., Gültekingil A., Bakirici O. Et al. Comparison of clinical features and laboratory findings of coronavirus disease 2019 and influenza A and B infection in children: a single-center study // Clinical and Experimental Pediatrics. 2021, vol. 64 (7), p. 356-369.
[12]	Hüseynova İ. Y., Hasanov A. Q., Qafaraov İ. A. Predicting the Severity of COVID-19 Pneumonia in Children // American Journal of Biomedical and Life Sciencec, - 2022. v. 10 (6), - p. 176-184.
[13]	Xia W, Shao J, Guo Y, et al. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. // Pediatr Pulmonol. 2020; 55 (5): 1169-74.
[14]	Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019 // Clin Chem Lab Med. 2020, vol. 58 (7), p. 1135-38.
[15]	Miromanov N. A., Miromanov A. M. Features of cytokine production in children with various variants of the flu course // Fundamental research. 2014, vol. 10 (6), pp. 1160-1165.
[16]	Smirnov İ. E., Mityushin İ. L., Kucherenko A. G. et al. Cytokine profilr in bakterial and viral infection in children // Scicntific centreof children Healthcare. 2014.№4, c. 14-19.
[17]	Hala K. Ş., Hanan M. L., Naglaa F. Et al. Cytokine profiypfile in Egyptian children and adolescent with COVID-19 pneumonia: A multicenter study // Pediatr pulmonol. 2021. v. 56 (12), p. 3924-3933.
[18]	Qian G., Zhang Y., Xu Y. et al. Reduced inflammatory respones to SARS-CoV-2 infection in children presenting to hospital with COVID-19 in China // Clinical Medicine. 2021. v. 34, p. 100831.
[19]	Ulhaq Z. S., Soraya G. V. İnterleukin 6 as a potential biomarker of COVID-19 progression // J. Med. Mal İnfect. 2020. v. 50 (4), p. 382-383.
[20]	Curatola A., Chiaretti A., Ferrenti C. et al. Cytokine response to SARS-CoV-2 infektion in children. // J. Viruses, -2021, vol. 13 (9), 1868.
[21]	Schooling C. M., Au Yeung S. L. Interleukin 18 and COVID-19 // Epidemiol İnfect., 2021. v. 150, e14. doi: 10.1017/SO950268821002636.
[22]	Stefano C., Michele P., Sherman H. et al. When does the cytokine storm begin in COVID-19 patients. A quick score to recognize it // Clin. Med. 2021. v. 10 (2), p. 297.

Cite This Article

Plain Text BibTeX RIS

APA Style

Huseynova Ilhama Yelmar, Hasanov Alekber Qazanfar, Mammadova Fakhriya Makhmud, Gafarov Ismayıl Adil. (2023). Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children. American Journal of Pediatrics, 9(3), 171-179. https://doi.org/10.11648/j.ajp.20230903.21

Copy | Download

ACS Style

Huseynova Ilhama Yelmar; Hasanov Alekber Qazanfar; Mammadova Fakhriya Makhmud; Gafarov Ismayıl Adil. Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children. Am. J. Pediatr. 2023, 9(3), 171-179. doi: 10.11648/j.ajp.20230903.21

Copy | Download

AMA Style

Huseynova Ilhama Yelmar, Hasanov Alekber Qazanfar, Mammadova Fakhriya Makhmud, Gafarov Ismayıl Adil. Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children. Am J Pediatr. 2023;9(3):171-179. doi: 10.11648/j.ajp.20230903.21

Copy | Download

@article{10.11648/j.ajp.20230903.21,
  author = {Huseynova Ilhama Yelmar and Hasanov Alekber Qazanfar and Mammadova Fakhriya Makhmud and Gafarov Ismayıl Adil},
  title = {Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children},
  journal = {American Journal of Pediatrics},
  volume = {9},
  number = {3},
  pages = {171-179},
  doi = {10.11648/j.ajp.20230903.21},
  url = {https://doi.org/10.11648/j.ajp.20230903.21},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20230903.21},
  abstract = {Today, respiratory diseases are one of the most widespread pathologies of children, causing maximum morbidity. The aim of our study was to determine and analyze differences in clinical and laboratory data and outcomes among children hospitalized with respiratory diseases of COVID-19 and other etiologies. For this purpose, 164 patients under the age of 17 were involved in the study. Patients were divided into two groups: Group I included 89 (54.3%) patients diagnosed with CKD (upper respiratory tract diseases of various etiologies), Group II included 75 (45.7%) patients diagnosed with COVID-19 (PCR positive) pneumonia. During the clinical examination, intoxication, indigestion, auscultatory changes in the lungs, loss of sense of smell, muscle pains, etc., upper respiratory tract damage syndrome, catarrhal symptoms, rhinitis, hyperemia of yawning at various levels during CRX were more manifested during the clinical examination. In both comparison groups of sick children, the main leading symptoms in general were fever 122 (74.4%), cough 133 (81.1%). An increase in the concentration of pro-inflammatory cytokines (IL-1β, IL-6, Il-18) was observed in the blood of patients during both pathologies. Cytokine levels were more prominent increased during COVID-19 compared to ARDs. This indicates the severity of the inflammatory process during COVID-19. The study of the level of pro-inflammatory cytokines in the blood serum of COVID-19 patients allows to determine the progress and severity of the inflammatory process.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children
AU  - Huseynova Ilhama Yelmar
AU  - Hasanov Alekber Qazanfar
AU  - Mammadova Fakhriya Makhmud
AU  - Gafarov Ismayıl Adil
Y1  - 2023/08/22
PY  - 2023
N1  - https://doi.org/10.11648/j.ajp.20230903.21
DO  - 10.11648/j.ajp.20230903.21
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 171
EP  - 179
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20230903.21
AB  - Today, respiratory diseases are one of the most widespread pathologies of children, causing maximum morbidity. The aim of our study was to determine and analyze differences in clinical and laboratory data and outcomes among children hospitalized with respiratory diseases of COVID-19 and other etiologies. For this purpose, 164 patients under the age of 17 were involved in the study. Patients were divided into two groups: Group I included 89 (54.3%) patients diagnosed with CKD (upper respiratory tract diseases of various etiologies), Group II included 75 (45.7%) patients diagnosed with COVID-19 (PCR positive) pneumonia. During the clinical examination, intoxication, indigestion, auscultatory changes in the lungs, loss of sense of smell, muscle pains, etc., upper respiratory tract damage syndrome, catarrhal symptoms, rhinitis, hyperemia of yawning at various levels during CRX were more manifested during the clinical examination. In both comparison groups of sick children, the main leading symptoms in general were fever 122 (74.4%), cough 133 (81.1%). An increase in the concentration of pro-inflammatory cytokines (IL-1β, IL-6, Il-18) was observed in the blood of patients during both pathologies. Cytokine levels were more prominent increased during COVID-19 compared to ARDs. This indicates the severity of the inflammatory process during COVID-19. The study of the level of pro-inflammatory cytokines in the blood serum of COVID-19 patients allows to determine the progress and severity of the inflammatory process.
VL  - 9
IS  - 3
ER  -

Copy | Download

Author Information

Huseynova Ilhama Yelmar

Department of Children's Diseases II, Azerbaijan Medical University, Baku, Azerbaijan
Hasanov Alekber Qazanfar

Department of Children's Diseases II, Azerbaijan Medical University, Baku, Azerbaijan
Mammadova Fakhriya Makhmud

Department of Children's Diseases II, Azerbaijan Medical University, Baku, Azerbaijan
Gafarov Ismayıl Adil

Department of Medical Physics and Informatics, Azerbaijan Medical University, Baku, Azerbaijan

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Huseynova Ilhama Yelmar, Hasanov Alekber Qazanfar, Mammadova Fakhriya Makhmud, Gafarov Ismayıl Adil. (2023). Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children. American Journal of Pediatrics, 9(3), 171-179. https://doi.org/10.11648/j.ajp.20230903.21

Copy | Download

ACS Style

Huseynova Ilhama Yelmar; Hasanov Alekber Qazanfar; Mammadova Fakhriya Makhmud; Gafarov Ismayıl Adil. Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children. Am. J. Pediatr. 2023, 9(3), 171-179. doi: 10.11648/j.ajp.20230903.21

Copy | Download

AMA Style

Huseynova Ilhama Yelmar, Hasanov Alekber Qazanfar, Mammadova Fakhriya Makhmud, Gafarov Ismayıl Adil. Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children. Am J Pediatr. 2023;9(3):171-179. doi: 10.11648/j.ajp.20230903.21

Copy | Download

@article{10.11648/j.ajp.20230903.21,
  author = {Huseynova Ilhama Yelmar and Hasanov Alekber Qazanfar and Mammadova Fakhriya Makhmud and Gafarov Ismayıl Adil},
  title = {Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children},
  journal = {American Journal of Pediatrics},
  volume = {9},
  number = {3},
  pages = {171-179},
  doi = {10.11648/j.ajp.20230903.21},
  url = {https://doi.org/10.11648/j.ajp.20230903.21},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20230903.21},
  abstract = {Today, respiratory diseases are one of the most widespread pathologies of children, causing maximum morbidity. The aim of our study was to determine and analyze differences in clinical and laboratory data and outcomes among children hospitalized with respiratory diseases of COVID-19 and other etiologies. For this purpose, 164 patients under the age of 17 were involved in the study. Patients were divided into two groups: Group I included 89 (54.3%) patients diagnosed with CKD (upper respiratory tract diseases of various etiologies), Group II included 75 (45.7%) patients diagnosed with COVID-19 (PCR positive) pneumonia. During the clinical examination, intoxication, indigestion, auscultatory changes in the lungs, loss of sense of smell, muscle pains, etc., upper respiratory tract damage syndrome, catarrhal symptoms, rhinitis, hyperemia of yawning at various levels during CRX were more manifested during the clinical examination. In both comparison groups of sick children, the main leading symptoms in general were fever 122 (74.4%), cough 133 (81.1%). An increase in the concentration of pro-inflammatory cytokines (IL-1β, IL-6, Il-18) was observed in the blood of patients during both pathologies. Cytokine levels were more prominent increased during COVID-19 compared to ARDs. This indicates the severity of the inflammatory process during COVID-19. The study of the level of pro-inflammatory cytokines in the blood serum of COVID-19 patients allows to determine the progress and severity of the inflammatory process.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Comparison of Clinical and Laboratory Characteristics of COVID-19 and Respiratory Diseases of Other Etiology in Hospitalized Children
AU  - Huseynova Ilhama Yelmar
AU  - Hasanov Alekber Qazanfar
AU  - Mammadova Fakhriya Makhmud
AU  - Gafarov Ismayıl Adil
Y1  - 2023/08/22
PY  - 2023
N1  - https://doi.org/10.11648/j.ajp.20230903.21
DO  - 10.11648/j.ajp.20230903.21
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 171
EP  - 179
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20230903.21
AB  - Today, respiratory diseases are one of the most widespread pathologies of children, causing maximum morbidity. The aim of our study was to determine and analyze differences in clinical and laboratory data and outcomes among children hospitalized with respiratory diseases of COVID-19 and other etiologies. For this purpose, 164 patients under the age of 17 were involved in the study. Patients were divided into two groups: Group I included 89 (54.3%) patients diagnosed with CKD (upper respiratory tract diseases of various etiologies), Group II included 75 (45.7%) patients diagnosed with COVID-19 (PCR positive) pneumonia. During the clinical examination, intoxication, indigestion, auscultatory changes in the lungs, loss of sense of smell, muscle pains, etc., upper respiratory tract damage syndrome, catarrhal symptoms, rhinitis, hyperemia of yawning at various levels during CRX were more manifested during the clinical examination. In both comparison groups of sick children, the main leading symptoms in general were fever 122 (74.4%), cough 133 (81.1%). An increase in the concentration of pro-inflammatory cytokines (IL-1β, IL-6, Il-18) was observed in the blood of patients during both pathologies. Cytokine levels were more prominent increased during COVID-19 compared to ARDs. This indicates the severity of the inflammatory process during COVID-19. The study of the level of pro-inflammatory cytokines in the blood serum of COVID-19 patients allows to determine the progress and severity of the inflammatory process.
VL  - 9
IS  - 3
ER  -

Copy | Download